Allen Cheng
banner
peripatetical.bsky.social
Allen Cheng
@peripatetical.bsky.social
Infectious diseases physician, epidemiologist. Melbourne, Australia.
Not my area of expertise, but I understand there are restrictions on the use of the Individual Healthcare Identifier so that it can't be used in linkage. But I could be wrong - others might know.
December 6, 2024 at 4:39 AM
Very annoying when you’re writing a manuscript - can’t easily find/replace to change full stops to interpuncts. I understand it’s a historical anachronism, like the New Yorker using diaereses (coöperation”) en.m.wikipedia.org/wiki/Interpu...
Interpunct - Wikipedia
en.m.wikipedia.org
December 3, 2024 at 7:41 PM
My father's family were originally rice farmers in China, and I ended up doing my PhD on melioidosis, a disease of rice farmers, partly based in Thailand where many of his siblings moved to (and where my cousin is an infectious diseases physician).
November 27, 2024 at 12:38 AM
C is the Schrödinger's result - simultaneously inferior and non-inferior.
November 26, 2024 at 7:37 PM
I've been off social media mostly for almost three years, was enticed back by Tony Korman, and tentitively wading back in!
November 21, 2024 at 2:33 AM
Supports routinely using 7 days of treatment in bacteraemia (other than S aureus, fungaemia, and if there is a definite indication for longer eg endocarditis)
November 21, 2024 at 2:02 AM
90 day mortality was *lower* in 7 day group (14.5%) vs 14 day group (16.1%); met non-inferiority criteria
There were no major differences between shorter/longer groups in subgroups, i8ncluding ICU, APACHE-II >25, by site or pathogen.
November 21, 2024 at 2:02 AM
Broad variety of infection sites but majority gram neg (71%); clear separation in duration between shorter group (median 8 days) vs longer duration group (median 14 days)
November 21, 2024 at 2:02 AM
It included ICU patients (55% of enrolled patients) but notably excluded immunocompromised, S aureus, candida, deep infection (eg endocarditis).
November 21, 2024 at 2:02 AM
This was a large trial (n=3608) at 74 hospitals in 7 countries. (COI: The Australian arm was co-ordinated from Monash by Ben Rogers). It was a non inferiority, 7 vs 14 days of treatment; primary outcome 90 day mortality.
November 21, 2024 at 2:02 AM
Thanks for coming to Melbourne! It's been an honour to have you join our ID community here and benefit from your expertise.
November 16, 2024 at 12:09 AM
28. In community-acquired infection, resistant organisms do not cause more severe illness than their sensitive counterparts. The only reason for using broader than usual therapy is when you (and the patient) cannot afford to be wrong.
November 16, 2024 at 12:03 AM
27. When you suspect bacteraemia, do not wait for the patient’s temperature to go up before doing blood cultures.
November 16, 2024 at 12:03 AM
26. In patients with unexplained neurological features, think of the five great infective mimics: HIV, syphilis, tuberculosis, Lyme disease (with epidemiological history), Whipple’s disease.
November 16, 2024 at 12:03 AM
25. Bacterial aortitis needs to be excluded in a patient who develops abdominal pain or back pain within weeks of an episode of diarrhoea.
November 16, 2024 at 12:03 AM
24. Remember that Listeria monocytogenes meningoencephalitis can masquerade clinically as herpes simplex encephalitis.
November 16, 2024 at 12:03 AM
23. Avoid the term “atypical pneumonia” in children, adults over the age of 50 years, the immunocompromised, the severely ill, or patients with diffuse bilateral interstitial pulmonary infiltrates.
November 16, 2024 at 12:03 AM